1. MO-0137 A basis for combining atovaquone-mediated hypoxia alleviation with immunotherapy plus radiotherapy. (May 2022) Authors: Rodriguez-Berriguete, G.; Puliyadi, R.; Prevo, R.; Pugh, C.W.; Higgins, G.S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-0747: Validation of the survival model including cardiac substructure dosimetry in NSCLC. (April 2018) Authors: Vivekanandan, S.; Panakis, N.; Higgins, G.S.; Stuart, R.; Landau, D.B.; Cooke, R.; Chu, K.Y.; Fresen, J.; Fenwick, J.D.; Hawkins, M.A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0539: Biological Precision in Radiotherapy. (April 2018) Authors: McKenna, G.; Muschel, R.J.; Higgins, G.S. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SP-0584: High throughput biological screens and their translation to new targets. (April 2015) Authors: McKenna, W.G.; Prevo, R.; Muschel, R.J.; Ashton, T.; Higgins, G.S. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗